Drugs

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
Rupesh Agrawal, Ilaria Testi, Cecilia S Lee, Edmund Tsui, Marian Blazes, Jennifer E Thorne, Annabelle A Okada, Justine R Smith, Peter J McCluskey, John H Kempen, Christoph Tappeiner, Manisha Agarwal, Bahram Bodaghi, Quan Dong Nguyen, Vishali Gupta, Marc D De Smet, Manfred Zierhut, Carlos Pavesio

British Journal of Ophthalmology Jun 2020, bjophthalmol-2020-316776; DOI: 10.1136/bjophthalmol-2020-316776
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
Hong Liang, Antoine Labbé, Christophe Baudouin, Celine Plisson, Vincenzo Giordano

British Journal of Ophthalmology Jun 2020, bjophthalmol-2020-316450; DOI: 10.1136/bjophthalmol-2020-316450
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
Augusto Azuara-Blanco, Nicola Logan, Niall Strang, Kathryn Saunders, Peter M Allen, Ruth Weir, Paul Doherty, Catherine Adams, Evie Gardner, Ruth Hogg, Margaret McFarland, Jennifer Preston, Rejina Verghis, James J Loughman, Ian Flitcroft, David A Mackey, Samantha Sze-Yee Lee, Christopher Hammond, Nathan Congdon, Mike Clarke

British Journal of Ophthalmology Jul 2020, 104 (7) 950-955; DOI: 10.1136/bjophthalmol-2019-314819
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs
Zheng Xian Thng, Marc D De Smet, Cecilia S Lee, Vishali Gupta, Justine R Smith, Peter J McCluskey, Jennifer E Thorne, John H Kempen, Manfred Zierhut, Quan Dong Nguyen, Carlos Pavesio, Rupesh Agrawal

British Journal of Ophthalmology Jun 2020, bjophthalmol-2020-316586; DOI: 10.1136/bjophthalmol-2020-316586
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study
Ha-Lim Jeon, Seong Jun Byun, Nicole L Pratt, Janet Sultana, Sang Jun Park, Ju-Young Shin

British Journal of Ophthalmology Jun 2020, bjophthalmol-2020-316373; DOI: 10.1136/bjophthalmol-2020-316373
Medical treatment in thyroid eye disease in 2020
Jwu Jin Khong, Alan McNab

British Journal of Ophthalmology May 2020, bjophthalmol-2020-316051; DOI: 10.1136/bjophthalmol-2020-316051
Local therapy for cancer therapy-associated uveitis: a case series and review of the literature
Arthi Ganesh Venkat, Sruthi Arepalli, Sumit Sharma, Naveen Karthik, Careen Lowder, Justis P Ehlers, Arun Singh, Jeffrey Goshe, Sunil Srivastava

British Journal of Ophthalmology May 2020, 104 (5) 703-711; DOI: 10.1136/bjophthalmol-2019-314403
Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yuko Maruyama, Yoko Ikeda, Kazuhiko Mori, Kengo Yoshii, Morio Ueno, Haruna Yoshikawa, Chie Sotozono, Shigeru Kinoshita

British Journal of Ophthalmology Apr 2020, bjophthalmol-2019-315776; DOI: 10.1136/bjophthalmol-2019-315776
Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases
Vincenzo Papa, Paolo Rama, Cherry Radford, Darwin C Minassian, John K G Dart

British Journal of Ophthalmology Apr 2020, 104 (4) 575-581; DOI: 10.1136/bjophthalmol-2019-314485
Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Heather Waterman, Simon Read, James Edwards Morgan, David Gillespie, Claire Nollett, Davina Allen, Marjorie Weiss, Pippa Anderson

British Journal of Ophthalmology Mar 2020, bjophthalmol-2019-315436; DOI: 10.1136/bjophthalmol-2019-315436

Main menu

Drugs

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Drugs

Pages